Request for Covid-19 Impact Assessment of this Report
Market Dynamics
The rapidly growing demand for diagnostic testing along with shrinking labor force of laboratory professionals is one of the prime drivers for automation in the drug discovery market. Moreover, increased government funding for biotech and drug discovery research, need for consistency in quality and a high cost of error act as growth drivers.
Lack of planning for technology development, low priority for lab automation among small and medium-sized laboratories and high initial setup cost put constraints on the market.
Market Segmentation
The global lab automation market is segmented by
--> Equipment and software (automated liquid handling, microplate readers, standalone robots, software and informatics, ASRS)
--> Type of automation (modular automation and total lab automation),
--> End users (biotech and pharma, hospitals and private labs, academics and research institutes).
Geographic Analysis
North America and Europe lead the global lab automation in drug discovery market along with Canada and Japan. Asia - Pacific and Latin American countries represent emerging markets.
Key Players
Some of the major players in the market include Tecan Group Ltd., PerkinElmer Inc., Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Danaher Corporation, Bosch Packaging Technology, Anton Paar, Labman, Siemens Healthcare, Synchron Lab Automation, Hamilton Robotics, and PAA Automation.
The report contains comprehensive analysis on:
--> Lab Automation in Drug Discovery Market Segments
--> Lab Automation in Drug Discovery Market Drivers, Restraints and Opportunities
--> Lab Automation in Drug Discovery Market Size & Forecast 2016 to 2022
--> Supply & Demand Value Chain
--> Lab Automation in Drug Discovery Market Current Trends
--> Competition & Major Companies
--> Technology and R&D Status
--> Porters Five Force Analysis
--> Strategic and Critical Success Factor Analysis of Key Players
Regional analysis for Cattle Health Market includes
--> North America
>> US and Canada
--> Latin America
>> Mexico, Brazil, Argentina and Rest of Latin America
--> Western Europe
>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe
--> Eastern Europe
>> Russia
>> Poland
>> Rest of Eastern Europe
--> Asia Pacific
>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific
--> Middle East and Africa
>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa
This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides in-depth market segmentation that is derived from extensive product mapping exercises, macro-economic factors and other qualitative and quantitative insights. The impact of all such factors are delivered across multiple market segments and geographies.
Report Highlights::
--> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
--> Consumer and Pricing Analysis
--> Market dynamics of the industry
--> In-depth Market Segmentation
--> Historical and Projected Market Sizing in terms of volume and value
--> Recent market trends and Impact Factors
--> R&D Status and Technology Overview
--> Extensive Industry Structure Coverage
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...